營養保健品市場按產品類型、形式、應用和地區分類（2026-2032 年）

營養保健品市場評估（2026-2032）

消費者健康意識的不斷增強，擴大轉向預防性保健解決方案和營養補充劑來管理與文明病，這是推動營養保健品市場發展的主要因素。預計到2024年，營養保健品市場的收益將達到3,842.7億美元，到2032年將達到4,537.8億美元。

科技和研究的進步正在催生創新的營養保健品配方，市場從 2026 年到 2032 年的複合年成長率將達到 2.10%。

營養保健品市場定義/概述

營養保健品是指提供超越基本營養的健康益處的食品，通常用於維持健康或預防疾病。這個術語由「營養」和「藥物」兩個詞組合而成，涵蓋範圍廣泛，包括膳食補充劑、機能性食品和草藥。

人們認為營養保健品具有生理益處，可以預防慢性疾病，並有助於促進健康、延緩老化以及增強身體結構和功能。雖然營養保健品來自食品，但它們通常以類似藥物的形式銷售，並且可能沒有經過與藥物同等嚴格的科學檢驗。各國對營養保健品的監管狀況各不相同，有些國家將其視為食品或補充劑，而非藥物。

人口老化將在營養保健品市場的成長中發揮什麼作用？

高齡化社會被認為是營養保健品市場成長的關鍵驅動力。據報道，到2030年，全球六分之一的人口將達到60歲或以上，凸顯了針對這一人群量身定做的健康解決方案的緊迫性。隨著人口老化，人們越來越重視預防與老齡化相關的疾病，這推動了對促進關節健康、認知功能和心血管健康的膳食補充劑和機能性食品的需求。

根據政府統計，與慢性病相關的醫療費用正在上升，鼓勵老年人透過營養保健品採取預防性醫療措施。

此外，研究表明，老年人越來越傾向於將營養補充劑納入日常生活，這進一步擴大了該領域的成長空間。隨著越來越多的人將透過食用營養保健品來維護健康和預防疾病作為優先事項，預計這種人口結構變化將繼續影響市場趨勢。

營養保健品市場在品管和標準化方面面臨的主要挑戰是什麼？

品管和標準化是營養保健品市場面臨的主要挑戰，主要原因是與藥品相比，營養保健品市場缺乏嚴格的監管標準。據報道，約70%的消費者對膳食補充劑的品質和安全表示擔憂，這凸顯了建立強力的品質保證措施的必要性。成分的自然差異往往會導致批次間產品不一致，從而損害產品功效並削弱消費者信心。

政府統計數據顯示，許多製造商未能遵守良好生產規範 (GMP)，導致生產過程中存在污染和品質問題的風險。因此，維持高品質標準的責任日益落在個體製造商身上，他們必須執行嚴格的測試通訊協定，並確保整個生產過程的可追溯性。由於缺乏普遍認可的品質基準，營養保健品產業在確保產品真實性和消費者安全方面仍面臨重大挑戰。

目錄

第 1 章全球營養保健品市場：簡介

• 市場概覽
• 分析範圍
• 先決條件

第2章執行摘要

第3章 已驗證的市場研究分析方法

• 資料探勘
• 驗證
• 第一手資料
• 資料來源列表

第4章全球營養保健品市場展望

• 概述
• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 波特五力模型
• 價值鏈分析

第5章。全球營養保健品市場（依產品類型）

• 概述
• 營養補充品
• 機能性食品
• 醫學營養
• 機能飲料

6. 全球營養保健品市場（依形式）

• 概述
• 錠劑
• 粉末
• 液體
• 軟糖

7. 全球營養保健品市場（按應用）

• 概述
• 預防醫學
• 疾病管理
• 體重管理
• 抗衰老

8. 全球營養保健品市場（按地區）

• 概述
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 其他地區 (ROW)
  • 拉丁美洲
  • 中東和非洲

第9章全球營養保健品市場的競爭格局

• 概述
• 各公司市場排名
• 主要發展策略

第10章 公司簡介

• Pfizer Inc.
• Nestle Health Science SA
• Amway Corporation
• Herbalife Nutrition Ltd.
• DSM
• The Hain Celestial Group, Inc.
• Abbott Laboratories
• Danone SA
• Sun Pharmaceutical Industries Ltd.
• NutraLife Corporation

第11章 附錄

• 相關分析

Nutraceutical Market Valuation - 2026-2032

The increasing health consciousness among consumers, who are more inclined to seek preventive healthcare solutions and dietary supplements to manage lifestyle-related disorders are the primary factor driving the nutraceutical market. The Nutraceutical Market is estimated to reach a valuation of USD 453.78 Billion by 2032 over the forecast by subjugating the revenue of USD 384.27 Billion valued in 2024.

Advancements in technology and research have led to innovative nutraceutical formulations, enabling the market to grow at a CAGR of 2.10% from 2026 to 2032.

Nutraceutical Market: Definition/ Overview

A nutraceutical is defined as a food product that provides health benefits beyond basic nutrition, often used to maintain health and prevent illness. The term, which combines "nutrition" and "pharmaceutical," encompasses a wide range of products, including dietary supplements, functional foods, and herbal remedies.

Nutraceuticals are believed to offer physiological benefits or protection against chronic diseases and can be utilized to improve health, delay aging, and enhance the body's structure or function. While they are derived from food sources, nutraceuticals are typically marketed in forms resembling medicinal products and may not have undergone the same rigorous scientific validation as pharmaceuticals. The regulatory status of nutraceuticals varies by country, with some jurisdictions treating them as foods or dietary supplements rather than drugs.

What Role does the Aging Population Play in Driving the Growth of the Nutraceutical Market?

The aging population is recognized as a significant driver of growth in the nutraceutical market, as an increasing number of individuals over the age of 65 are seeking products that support their health and well-being. It has been reported that by 2030, one in six people worldwide will be aged 60 years or older, highlighting the urgency for health-focused solutions tailored to this demographic. As people age, there is a heightened emphasis on preventing age-related diseases, leading to a greater demand for dietary supplements and functional foods that promote joint health, cognitive function, and cardiovascular wellness.

Government statistics indicate that healthcare costs associated with chronic diseases are rising, prompting older adults to adopt preventive healthcare measures through nutraceuticals.

Additionally, studies have shown that older adults are increasingly recommended to incorporate dietary supplements into their daily routines, further boosting the scope for growth in this sector. This demographic shift is expected to continue influencing market trends as more individuals prioritize health maintenance and disease prevention through nutraceutical consumption.

What are the Main Challenges Related to Quality Control and Standardization in the Nutraceutical Market?

Quality control and standardization are major challenges in the nutraceutical market, primarily due to the lack of stringent regulatory standards compared to pharmaceuticals. It has been reported that approximately 70% of consumers express concerns regarding the quality and safety of dietary supplements, which underscores the necessity for robust quality assurance measures. The natural variability of ingredients often results in batch-to-batch inconsistencies, potentially compromising product efficacy and eroding consumer trust.

Government statistics highlight that many manufacturers fail to adhere to Good Manufacturing Practices (GMP), leading to risks of contamination and quality issues during production. As a result, the responsibility for maintaining high-quality standards increasingly falls on individual manufacturers, who must implement rigorous testing protocols and ensure traceability throughout the production process. Without universally accepted benchmarks for quality, significant challenges persist in ensuring product reliability and consumer safety within the nutraceutical industry.

Category-Wise Acumens

How do Consumer Preferences for Natural Health Solutions Contribute to the Dominance of Dietary Supplements in the Nutraceutical Market?

Consumer preferences for natural health solutions significantly contribute to the dominance of dietary supplements in the nutraceutical market, as an increasing number of individuals are gravitating towards products perceived as safer and more effective for health maintenance. It has been reported that approximately 70% of consumers express a preference for natural ingredients, particularly for preventive health measures rather than curative ones, indicating a strong inclination towards dietary supplements that promise enhanced well-being without the side effects often associated with synthetic medications.

Government statistics from the Ministry of Food Processing Industries highlight a notable shift in purchasing patterns, with many consumers now favoring immunity-boosting supplements and herbal products over traditional pharmaceuticals for minor health issues. This trend is further supported by a growing awareness of the health benefits associated with dietary supplements, which is reflected in the increasing consumer willingness to invest in products that align with their values of sustainability and natural wellness. As a result, the nutraceutical market is being shaped by these evolving consumer preferences, leading to a robust demand for dietary supplements that cater to the desire for holistic health solutions.

How has the COVID-19 Pandemic Influenced the Emphasis on Preventive Healthcare Within the Nutraceutical Market?

The COVID-19 pandemic has significantly influenced the emphasis on preventive healthcare within the nutraceutical market, as consumers increasingly seek solutions to enhance their immunity and overall health. It has been observed that the demand for dietary supplements surged during the pandemic, with many individuals turning to nutraceuticals as a proactive measure against health threats. Government data from the Food Safety and Standards Authority of India (FSSAI) indicate that there was a notable shift in consumer behavior, with a marked increase in the purchase of immunity-boosting supplements such as vitamins C and D, zinc, and probiotics. Approximately 15% of India's population is reported to be undernourished, highlighting the critical role that nutraceuticals can play in addressing nutritional deficiencies exacerbated by the pandemic.

Furthermore, initiatives such as the National Health Mission have underscored the importance of nutrition in public health policies, thereby reinforcing the relevance of nutraceuticals as essential components of preventive healthcare strategies. As a result, a lasting impact on consumer attitudes towards health and wellness has been established, positioning nutraceuticals as vital tools in promoting preventive care in a post-pandemic world.

What Factors Contribute to North America's Position as a Leader in the Nutraceutical Market?

North America's position as a leader in the global nutraceutical market is influenced by several key factors, primarily driven by consumer demand for health-focused products. It has been reported that approximately 35.2% of the nutraceutical market share is held by this region, reflecting a strong preference for preventive healthcare solutions among consumers. Government statistics from the Centers for Disease Control and Prevention (CDC) indicate that nearly 70% of adults in the U.S. are seeking dietary supplements to enhance their health and prevent chronic diseases. The aging population in North America also plays a crucial role, as older adults increasingly turn to nutraceuticals to manage age-related health issues.

Additionally, rising healthcare costs, which account for about 14% of the U.S. gross national product, have prompted consumers to seek cost-effective preventive measures through dietary supplements and functional foods. Furthermore, regulatory support for functional food innovations and increased research and development efforts by companies are fostering a competitive environment that enhances product availability and consumer trust in nutraceuticals. As a result, these factors collectively contribute to North America's dominant position in the nutraceutical market.

What Factors Contribute to the Rapid Growth of the Nutraceutical Market in Asia Pacific Region?

The rapid growth of the nutraceutical market in the Asia Pacific region is driven by several key factors, primarily related to changing consumer preferences and increasing health awareness. It has been reported that approximately 40% of the demand for nutraceuticals originated from Asia Pacific in 2022, reflecting a strong regional inclination towards preventive healthcare solutions. Government statistics from the World Health Organization indicate that the prevalence of chronic diseases such as diabetes and cardiovascular conditions is rising, prompting consumers to seek dietary supplements to enhance their health and immunity.

Additionally, various government initiatives, including the Poshan Abhiyan in India aimed at eradicating malnutrition, have promoted awareness about the importance of nutrition in disease prevention. Furthermore, the legalization of hemp cultivation in several countries has led to an increase in cannabis-based nutraceutical products, catering to evolving consumer interests. As a result, these factors collectively contribute to the dynamic expansion of the nutraceutical market in the Asia Pacific region, positioning it as a significant player on the global stage.

Competitive Landscape

The competitive landscape of the nutraceutical market is characterized by a mix of established international players and emerging companies, all striving for market share through innovation and strategic initiatives. The rising trend of veganism and clean-label products is influencing product formulations, leading to increased demand for botanical ingredients. With an advanced distribution network supporting these efforts, the competitive dynamics within the nutraceutical market are expected to continue evolving as companies adapt to changing consumer preferences and health trends.

Some of the prominent players operating in the nutraceutical market include:

Pfizer,

Nestle Health Science A.

Amway Corporation

Herbalife Nutrition

DSM

The Hain Celestial Group,

Abbott Laboratories

Danone A.

Sun Pharmaceutical Industries

NutraLife Corporation

Latest Developments

In March 2023, Pfizer announced a definitive merger agreement to acquire Seagen Inc. for USD 43 Billion, aiming to enhance its oncology portfolio and potentially expand into nutraceutical applications that support cancer treatment and overall health.

In February 2023, DSM launched life's(R)OMEGA O3020, a new algal oil product aimed at providing a sustainable alternative to fish oil, addressing consumer demand for plant-based omega-3 fatty acids.

Nutraceutical Market, By Category Product Type:

• Dietary Supplements
• Functional Foods
• Medical Nutrition
• Functional Beverages
• Form:
• Tablets
• Powders
• Liquids
• Gummies
• Application:
• Preventive Healthcare
• Disease Management
• Weight Management
• Anti-Aging
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NUTRACEUTICAL MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NUTRACEUTICAL MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NUTRACEUTICAL MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Dietary Supplements
• 5.3 Functional Foods
• 5.4 Medical Nutrition
• 5.5 Functional Beverages

6 GLOBAL NUTRACEUTICAL MARKET, BY FORM

• 6.1 Overview
• 6.2 Tablets
• 6.3 Powders
• 6.4 Liquids
• 6.5 Gummies

7 GLOBAL NUTRACEUTICAL MARKET, BY APPLICATION

• 7.1 Overview
• 7.2 Preventive Healthcare
• 7.3 Disease Management
• 7.4 Weight Management
• 7.5 Anti-Aging

8 GLOBAL NUTRACEUTICAL MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL NUTRACEUTICAL MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Pfizer Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Nestle Health Science S.A.
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Amway Corporation
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Herbalife Nutrition Ltd.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 DSM
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 The Hain Celestial Group, Inc.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Abbott Laboratories
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Danone S.A.
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Sun Pharmaceutical Industries Ltd.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 NutraLife Corporation
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Reports